Re-thinking the treatment of depression: have we been misinformed about antidepressants? A webinar discussion with Irving Kirsch, Ph.D. and Michael D. Yapko, Ph.D.
{"title":"Re-thinking the treatment of depression: have we been misinformed about antidepressants? A webinar discussion with Irving Kirsch, Ph.D. and Michael D. Yapko, Ph.D.","authors":"Irving Kirsch, Michael D Yapko","doi":"10.1080/00029157.2024.2343624","DOIUrl":null,"url":null,"abstract":"<p><p>This article provides an edited transcript of a moderated discussion between depression experts Irving Kirsch and Michael Yapko regarding the role of antidepressants in the treatment of major depression. It includes references to the role of expectancy and the merits of hypnosis in treatment. This presentation was sponsored by <i>MindsetHealth</i>, an Australian-based digital therapeutics company (mindsethealth.com) and took place online on March 28, 2023. As a webinar offered at no cost, it was open to anyone with an interest in the subject. Dr. Kirsch described his landmark research on the placebo effect and its curious relationship to the presumed merits of antidepressant medications. Dr. Yapko discussed the limitations of drug treatment based on the substantial evidence indicating that depression is much more a social problem than a medical one. The moderator for this discussion is Claire Davidson, who serves as the Research Lead at <i>MindsetHealth</i>. Drs. Kirsch and Yapko both serve on the <i>MindsetHealth</i> Scientific Advisory Board.</p>","PeriodicalId":46304,"journal":{"name":"American Journal of Clinical Hypnosis","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Clinical Hypnosis","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1080/00029157.2024.2343624","RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/20 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 0
Abstract
This article provides an edited transcript of a moderated discussion between depression experts Irving Kirsch and Michael Yapko regarding the role of antidepressants in the treatment of major depression. It includes references to the role of expectancy and the merits of hypnosis in treatment. This presentation was sponsored by MindsetHealth, an Australian-based digital therapeutics company (mindsethealth.com) and took place online on March 28, 2023. As a webinar offered at no cost, it was open to anyone with an interest in the subject. Dr. Kirsch described his landmark research on the placebo effect and its curious relationship to the presumed merits of antidepressant medications. Dr. Yapko discussed the limitations of drug treatment based on the substantial evidence indicating that depression is much more a social problem than a medical one. The moderator for this discussion is Claire Davidson, who serves as the Research Lead at MindsetHealth. Drs. Kirsch and Yapko both serve on the MindsetHealth Scientific Advisory Board.
期刊介绍:
The American Journal of Clinical Hypnosis ( AJCH) is the official publication of the American Society of Clinical Hypnosis (ASCH). The Journal publishes original scientific articles and clinical case reports on hypnosis, as well as books reviews and abstracts of the current hypnosis literature. The purview of AJCH articles includes multiple and single case studies, empirical research studies, models of treatment, theories of hypnosis, and occasional special articles pertaining to hypnosis. The membership of ASCH and readership of AJCH includes licensed health care professionals and university faculty in the fields of medicine, psychiatry, clinical social work, clinical psychology, dentistry, counseling, and graduate students in these disciplines. AJCH is unique among other hypnosis journals because its primary emphasis on professional applications of hypnosis.